Sign in

CIK 0001231457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

GENELUX Corp

Sign in to watch
Ticker
GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 805-267-9889
Business address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
  1. 4 Open-market sale VP, Clinical Trial Operations sold 5,200 shares at $19.11 ($99,351)
  2. 4 Open-market sale Director sold 3,333 shares at an average $20.71 ($69,038)
  3. 4 Open-market sale VP, Clinical Trial Operations sold 5,200 shares at an average $22.01 ($114,462)
  4. 4 Open-market sale 10% owner sold 14,251 shares at an average $24.93 ($355,229)
  5. 4 Open-market sale 10% owner sold 75,690 shares at $25.49 ($1,929,225)
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale 10% owner sold 13,546 shares at an average $24.41 ($330,669)
  8. 4 Open-market sale 10% owner sold 42,263 shares at an average $24.38 ($1,030,181)
  9. 4 Open-market sale VP, Clinical Trial Operations sold 5,200 shares at an average $23.56 ($122,528)
  10. 4 Open-market sale 10% owner sold 16,591 shares at an average $27.85 ($462,001)
  11. 4 Open-market sale VP, Clinical Trial Operations sold 6,000 shares at $27.96 ($167,786)
  12. 4 Open-market sale General Counsel sold 10,000 shares at $30.00 ($300,000)
  13. 4 Open-market sale 10% owner sold 62,459 shares at an average $24.92 ($1,556,591)
  14. 4 Open-market sale VP, Clinical Trial Operations sold 10,400 shares at an average $21.89 ($227,630)
  15. 4 Open-market sale Director sold 6,667 shares at an average $23.45 ($156,313)
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale VP, Clinical Trial Operations sold 29,800 shares at $21.14 ($629,927)
  18. 4 Open-market sale 10% owner sold 44,308 shares at an average $21.80 ($965,899)
  19. 4 Open-market sale Director sold 900 shares at $20.78 ($18,702)
  20. 4 Grant or award Director acquired 3,460 shares (grant or award)

Page 7 of 10 · 190 filings